I'm still struggling to accept the fiftyonecapital report's assumption of 90% success on the phase 2 trial. That's a fairly bold statement.
The phase 1 trials should have been somewhat expected as similar studies have been done before. Also, i didn't see any mention about any results so far relative to a placebo group.
In saying that ,I haven't spent a huge amount of time on this so i hope i'm wrong as we can continue to ride the wave. DYOR
I'm still struggling to accept the fiftyonecapital report's...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
0.055(20.4%) |
Mkt cap ! $82.30M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 33.5¢ | 27.5¢ | $1.328M | 4.323M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4624 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 152597 | 4 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |
